Menu

Filtros : "FARMACOCINÉTICA" "Bou-Chacra, Nadia Araci" Removido: "Marins, Débora Soares Souza" Limpar

Filtros

Refine with date range

  • 1

1 - 8 (8 records)

  • Artigo de periodico

    In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors (2024)

    Yousef, Malaz ; O’Croinin, Conor; Le, Tyson S; Park, Chulhun ; Zuo, Jieyu; Bou-Chacra, Nadia Araci ; Davies, Neal M ; Löbenberg, Raimar

    Source: Pharmaceutics. Unidade: FCF

    Subjects: FARMACOCINÉTICA, FARMACODINÂMICA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      YOUSEF, Malaz et al. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, v. 16, n. 6 p. 1-13 art. 768, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics16060768. Acesso em: 04 out. 2024.

    • APA

      Yousef, M., O’Croinin, C., Le, T. S., Park, C., Zuo, J., Bou-Chacra, N. A., et al. (2024). In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, 16( 6 p. 1-13 art. 768). doi:10.3390/pharmaceutics16060768

    • NLM

      Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 out. 04 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768

    • Vancouver

      Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 out. 04 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768

  • Artigo de periodico

    Drug nanocrystals in oral absorption: factors that influence pharmacokinetics (2024)

    Macedo, Luiza de Oliveira ; Masiero, Jéssica Fagionato ; Bou-Chacra, Nadia Araci

    Source: Pharmaceutics. Unidade: FCF

    Subjects: FARMACOCINÉTICA, BIODISPONIBILIDADE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MACEDO, Luiza de Oliveira e MASIERO, Jéssica Fagionato e BOU-CHACRA, Nadia Araci. Drug nanocrystals in oral absorption: factors that influence pharmacokinetics. Pharmaceutics, v. 16, n. 9, p. 1-21 art. 1141, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics16091141. Acesso em: 04 out. 2024.

    • APA

      Macedo, L. de O., Masiero, J. F., & Bou-Chacra, N. A. (2024). Drug nanocrystals in oral absorption: factors that influence pharmacokinetics. Pharmaceutics, 16( 9), 1-21 art. 1141. doi:10.3390/pharmaceutics16091141

    • NLM

      Macedo L de O, Masiero JF, Bou-Chacra NA. Drug nanocrystals in oral absorption: factors that influence pharmacokinetics [Internet]. Pharmaceutics. 2024 ; 16( 9): 1-21 art. 1141.[citado 2024 out. 04 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16091141

    • Vancouver

      Macedo L de O, Masiero JF, Bou-Chacra NA. Drug nanocrystals in oral absorption: factors that influence pharmacokinetics [Internet]. Pharmaceutics. 2024 ; 16( 9): 1-21 art. 1141.[citado 2024 out. 04 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16091141

  • Artigo de periodico

    Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions (2022)

    Silva, Daniela Amaral ; Davies, Neal M; Bou-Chacra, Nadia Araci ; Ferraz, Humberto Gomes ; Löbenberg, Raimar

    Source: Dissolution Technologies. Unidade: FCF

    Subjects: TRATO GASTROINTESTINAL, FARMACOCINÉTICA, MEDICAMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SILVA, Daniela Amaral et al. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions. Dissolution Technologies, v. 29, n. 2, p. 62-75, 2022Tradução . . Disponível em: https://doi.org/10.14227/DT290222P62. Acesso em: 04 out. 2024.

    • APA

      Silva, D. A., Davies, N. M., Bou-Chacra, N. A., Ferraz, H. G., & Löbenberg, R. (2022). Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions. Dissolution Technologies, 29( 2), 62-75. doi:10.14227/DT290222P62

    • NLM

      Silva DA, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions [Internet]. Dissolution Technologies. 2022 ; 29( 2): 62-75.[citado 2024 out. 04 ] Available from: https://doi.org/10.14227/DT290222P62

    • Vancouver

      Silva DA, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions [Internet]. Dissolution Technologies. 2022 ; 29( 2): 62-75.[citado 2024 out. 04 ] Available from: https://doi.org/10.14227/DT290222P62

  • Artigo de periodico

    Innovative drug delivery systems for leprosy treatment (2022)

    Rocha, Nataly Paredes da ; Barbosa, Eduardo José ; Araujo, Gabriel Lima Barros de ; Bou-Chacra, Nadia Araci

    Source: Indian Journal of Dermatology. Unidade: FCF

    Subjects: HANSENÍASE, FARMACOCINÉTICA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      ROCHA, Nataly Paredes da et al. Innovative drug delivery systems for leprosy treatment. Indian Journal of Dermatology, v. 88, n. 3, p. 437-442, 2022Tradução . . Disponível em: https://doi.org/10.25259/ijdvl_1119_20. Acesso em: 04 out. 2024.

    • APA

      Rocha, N. P. da, Barbosa, E. J., Araujo, G. L. B. de, & Bou-Chacra, N. A. (2022). Innovative drug delivery systems for leprosy treatment. Indian Journal of Dermatology, 88( 3), 437-442. doi:10.25259/ijdvl_1119_20

    • NLM

      Rocha NP da, Barbosa EJ, Araujo GLB de, Bou-Chacra NA. Innovative drug delivery systems for leprosy treatment [Internet]. Indian Journal of Dermatology. 2022 ; 88( 3): 437-442.[citado 2024 out. 04 ] Available from: https://doi.org/10.25259/ijdvl_1119_20

    • Vancouver

      Rocha NP da, Barbosa EJ, Araujo GLB de, Bou-Chacra NA. Innovative drug delivery systems for leprosy treatment [Internet]. Indian Journal of Dermatology. 2022 ; 88( 3): 437-442.[citado 2024 out. 04 ] Available from: https://doi.org/10.25259/ijdvl_1119_20

  • Artigo de periodico

    A BCS-based biowaiver approach using biphasic dissolution test (2021)

    Silva, Daniela Amaral; Melo, Katherine Jasmine Curo; Davies, Neal M; Bou-Chacra, Nadia Araci ; Ferraz, Humberto Gomes ; Löbenberg, Raimar

    Source: Dissolution Technology. Unidade: FCF

    Subjects: BIOEQUIVALÊNCIA, FARMACOCINÉTICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SILVA, Daniela Amaral et al. A BCS-based biowaiver approach using biphasic dissolution test. Dissolution Technology, v. 28, n. 4, p. 40-48, 2021Tradução . . Disponível em: https://doi.org/10.14227/DT280421P40. Acesso em: 04 out. 2024.

    • APA

      Silva, D. A., Melo, K. J. C., Davies, N. M., Bou-Chacra, N. A., Ferraz, H. G., & Löbenberg, R. (2021). A BCS-based biowaiver approach using biphasic dissolution test. Dissolution Technology, 28( 4), 40-48. doi:10.14227/DT280421P40

    • NLM

      Silva DA, Melo KJC, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. A BCS-based biowaiver approach using biphasic dissolution test [Internet]. Dissolution Technology. 2021 ; 28( 4): 40-48.[citado 2024 out. 04 ] Available from: https://doi.org/10.14227/DT280421P40

    • Vancouver

      Silva DA, Melo KJC, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. A BCS-based biowaiver approach using biphasic dissolution test [Internet]. Dissolution Technology. 2021 ; 28( 4): 40-48.[citado 2024 out. 04 ] Available from: https://doi.org/10.14227/DT280421P40

  • Artigo de periodico

    Exploratory study on lercanidipine hydrochloride polymorphism: ph-dependent solubility behavior and simulation of its impact on pharmacokinetics (2021)

    Repin, Ilia Alekseevich; Loebenberg, Raimar ; DiBella, John; Conceição, António C. L; Piedade, Manuel E. Minas da ; Ferraz, Humberto Gomes ; Issa, Michele Georges ; Bou-Chacra, Nadia Araci ; Ermida, Catharine Fonseca Martins; Araujo, Gabriel Lima Barros de

    Source: AAPS PharmSciTech. Unidade: FCF

    Subjects: POLIMORFISMO, FARMACOCINÉTICA, SOLUBILIDADE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      REPIN, Ilia Alekseevich et al. Exploratory study on lercanidipine hydrochloride polymorphism: ph-dependent solubility behavior and simulation of its impact on pharmacokinetics. AAPS PharmSciTech, v. 22, p. 1-11 art. 54, 2021Tradução . . Disponível em: https://doi.org/10.1208/s12249-021-01923-0. Acesso em: 04 out. 2024.

    • APA

      Repin, I. A., Loebenberg, R., DiBella, J., Conceição, A. C. L., Piedade, M. E. M. da, Ferraz, H. G., et al. (2021). Exploratory study on lercanidipine hydrochloride polymorphism: ph-dependent solubility behavior and simulation of its impact on pharmacokinetics. AAPS PharmSciTech, 22, 1-11 art. 54. doi:10.1208/s12249-021-01923-0

    • NLM

      Repin IA, Loebenberg R, DiBella J, Conceição ACL, Piedade MEM da, Ferraz HG, Issa MG, Bou-Chacra NA, Ermida CFM, Araujo GLB de. Exploratory study on lercanidipine hydrochloride polymorphism: ph-dependent solubility behavior and simulation of its impact on pharmacokinetics [Internet]. AAPS PharmSciTech. 2021 ; 22 1-11 art. 54.[citado 2024 out. 04 ] Available from: https://doi.org/10.1208/s12249-021-01923-0

    • Vancouver

      Repin IA, Loebenberg R, DiBella J, Conceição ACL, Piedade MEM da, Ferraz HG, Issa MG, Bou-Chacra NA, Ermida CFM, Araujo GLB de. Exploratory study on lercanidipine hydrochloride polymorphism: ph-dependent solubility behavior and simulation of its impact on pharmacokinetics [Internet]. AAPS PharmSciTech. 2021 ; 22 1-11 art. 54.[citado 2024 out. 04 ] Available from: https://doi.org/10.1208/s12249-021-01923-0

  • Artigo de periodico

    The Significance of disintegration testing in pharmaceutical development (2018)

    Silva, Daniela Amaral; Webster, Gregory K; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar

    Source: Dissolution Technologies. Unidade: FCF

    Subjects: FARMACOCINÉTICA, MEDICAMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SILVA, Daniela Amaral et al. The Significance of disintegration testing in pharmaceutical development. Dissolution Technologies, v. 25, n. 3, p. 30-38, 2018Tradução . . Disponível em: https://doi.org/10.14227/DT250318P30. Acesso em: 04 out. 2024.

    • APA

      Silva, D. A., Webster, G. K., Bou-Chacra, N. A., & Löbenberg, R. (2018). The Significance of disintegration testing in pharmaceutical development. Dissolution Technologies, 25( 3), 30-38. doi:10.14227/DT250318P30

    • NLM

      Silva DA, Webster GK, Bou-Chacra NA, Löbenberg R. The Significance of disintegration testing in pharmaceutical development [Internet]. Dissolution Technologies. 2018 ; 25( 3): 30-38.[citado 2024 out. 04 ] Available from: https://doi.org/10.14227/DT250318P30

    • Vancouver

      Silva DA, Webster GK, Bou-Chacra NA, Löbenberg R. The Significance of disintegration testing in pharmaceutical development [Internet]. Dissolution Technologies. 2018 ; 25( 3): 30-38.[citado 2024 out. 04 ] Available from: https://doi.org/10.14227/DT250318P30

  • Artigo de periodico

    Evaluation of the DDSolver software applications (2014)

    Zuo, Jieyu; Gao, Yuan; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar

    Source: BioMed Research International. Unidade: FCF

    Subjects: SOFTWARES, FARMACOCINÉTICA, FÁRMACOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      ZUO, Jieyu et al. Evaluation of the DDSolver software applications. BioMed Research International, p. 1-9 art. 204925, 2014Tradução . . Disponível em: https://doi.org/10.1155/2014/204925. Acesso em: 04 out. 2024.

    • APA

      Zuo, J., Gao, Y., Bou-Chacra, N. A., & Löbenberg, R. (2014). Evaluation of the DDSolver software applications. BioMed Research International, 1-9 art. 204925. doi:10.1155/2014/204925

    • NLM

      Zuo J, Gao Y, Bou-Chacra NA, Löbenberg R. Evaluation of the DDSolver software applications [Internet]. BioMed Research International. 2014 ; 1-9 art. 204925.[citado 2024 out. 04 ] Available from: https://doi.org/10.1155/2014/204925

    • Vancouver

      Zuo J, Gao Y, Bou-Chacra NA, Löbenberg R. Evaluation of the DDSolver software applications [Internet]. BioMed Research International. 2014 ; 1-9 art. 204925.[citado 2024 out. 04 ] Available from: https://doi.org/10.1155/2014/204925
  • 1

1 - 8 (8 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024